| ||||
| Public Act 097-0170 | ||||
| ||||
| ||||
AN ACT concerning professional regulation.
| ||||
Be it enacted by the People of the State of Illinois,
| ||||
represented in the General Assembly:
| ||||
Section 5. The Illinois Optometric Practice Act of 1987 is | ||||
amended by changing Section 15.1 as follows:
| ||||
(225 ILCS 80/15.1)
| ||||
(Section scheduled to be repealed on January 1, 2017)
| ||||
Sec. 15.1. Diagnostic and therapeutic authority.
| ||||
(a) For purposes of the Act, "ocular pharmaceutical
agents" | ||||
means topical anesthetics, topical mydriatics, topical
| ||||
cycloplegics, topical miotics and mydriatic reversing agents, | ||||
anti-infective agents,
anti-allergy agents,
anti-glaucoma | ||||
agents (except oral carbonic anhydrase inhibitors, which may be | ||||
prescribed only in a quantity sufficient to provide treatment | ||||
for up to 72 hours),
anti-inflammatory agents (except oral | ||||
steroids), over-the-counter agents, and analgesic
agents, | ||||
anti-dry eye agents, and agents for the treatment of | ||||
hypotrichosis. | ||||
(a-3) In addition to ocular pharmaceutical agents that fall | ||||
within the categories set forth in subsection (a) of this | ||||
Section, the Board may add a pharmaceutical agent approved by | ||||
the FDA or class of agents for the purpose of the diagnosis or | ||||
treatment of conditions of the eye and adnexa after | ||||
consideration of the agent's systemic effects, side effects, | ||
and the use of the agent within the practice of optometry. The | ||
Board shall consider requests for additional agents and make | ||
recommendations within 90 days after the receipt of the | ||
request. | ||
Within 45 days after the Board's recommendation to the | ||
Department of a pharmaceutical agent or class of agents, the | ||
Department shall promulgate rules necessary to allow for the | ||
prescribing or administering of the pharmaceutical agent or | ||
class of agents under this Act. | ||
(a-5) Ocular pharmaceutical agents administered by | ||
injection may be used only for the treatment of anaphylaxis. | ||
(a-10) Oral pharmaceutical agents may be prescribed for a | ||
child under 5 years of age only in consultation with a | ||
physician licensed to practice medicine in all its branches. | ||
(a-15) The authority to prescribe a Schedule III, IV, or V | ||
controlled substance shall include only analgesic agents in a | ||
quantity sufficient to provide treatment for up to 72 hours. | ||
The prescription of a Schedule II controlled substance is | ||
prohibited.
| ||
(b) A licensed optometrist may remove superficial foreign | ||
bodies from the human eye and adnexa and may give orders for | ||
patient care to a nurse licensed to practice under Illinois | ||
law.
| ||
(c) An optometrist's license shall be revoked or suspended | ||
by the Department
upon recommendation of the Board based upon | ||
either of the
following causes: | ||
(1) grave or repeated misuse of any ocular
| ||
pharmaceutical agent; and | ||
(2) the use of any agent or procedure in the course of | ||
optometric practice
by an optometrist not properly | ||
authorized under this Act. | ||
(d) The Secretary of Financial and Professional Regulation | ||
shall notify
the Director of Public Health as to the categories | ||
of ocular
pharmaceutical agents permitted for use by an | ||
optometrist. The Director of Public Health shall in turn
notify | ||
every licensed pharmacist in the State of the categories of | ||
ocular
pharmaceutical agents that can be utilized and | ||
prescribed by an optometrist.
| ||
(Source: P.A. 94-787, eff. 5-19-06; 95-242, eff. 1-1-08.)
| ||
Section 99. Effective date. This Act takes effect upon | ||
becoming law. | ||